Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. (Record no. 24945043)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02142 a2200589 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517034053.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201603s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1592-8721 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.3324/haematol.2015.125849 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Zeidner, Joshua F |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20160321 |
245 00 - TITLE STATEMENT | |
Title | Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Haematologica |
Date of publication, distribution, etc. | Sep 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1172-9 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytarabine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Daunorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Flavonoids |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Follow-Up Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leukemia, Myeloid, Acute |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mitoxantrone |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Piperidines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Foster, Matthew C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Blackford, Amanda L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Litzow, Mark R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Morris, Lawrence E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Strickland, Stephen A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lancet, Jeffrey E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bose, Prithviraj |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Levy, M Yair |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tibes, Raoul |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gojo, Ivana |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gocke, Christopher D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rosner, Gary L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Little, Richard F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wright, John J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Doyle, L Austin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Smith, B Douglas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Karp, Judith E |
773 0# - HOST ITEM ENTRY | |
Title | Haematologica |
Related parts | vol. 100 |
-- | no. 9 |
-- | p. 1172-9 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.3324/haematol.2015.125849">https://doi.org/10.3324/haematol.2015.125849</a> |
Public note | Available from publisher's website |
No items available.